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Transcatheter Arterial Embolization of
Renal VX-2 Carcinoma: Ethiodol-Ethanol
Capillary Embolization Combined with
Carboplatin
Objective: We wanted to determine whether transcatheter Ethiodol-based cap-
illary embolization in combination with carboplatin could improve the efficiency of
a 1:1 Ethiodol-ethanol mixture (EEM) to ablate kidneys that been inoculated with
VX-2 carcinoma. 
Materials and Methods: The right kidney in 34 New Zealand white rabbits
were inoculated with fresh VX-2 tumor fragments. One week later, the kidneys
were subjected to transarterial treatment (4 5 rabbits/group): Saline infusion
(Group 1); carboplatin infusion (5 or 10 mg, Groups 2A and 2B); carboplatin-
Ethiodol (CE) alone (Group 3) and followed by main renal artery occlusion with
ethanol (RAO) (Group 4); carboplatin-EEM (C-EEM) followed by RAO (Group 5);
carboplatin infusion followed by EEM plus RAO (Group 6); and EEM followed by
RAO (Group 7). The animals were followed for up to 3-weeks. The treated kid-
neys were evaluated angiographically and macroscopically. The kidneys that
showed successful embolization macroscopically were entirely cut into serial sec-
tions, and these were examined microscopically. Histologically, the kidneys were
evaluated on the basis of the residual tumor found in the serial sections. 
Results: The results obtained with carboplatin infusion alone (Groups 2A and
2B) and CE without RAO (Group 3) were similar to those of the control animals
(Group 1). Kidneys from Groups 4 7 demonstrated macroscopically successful
embolization with histologically proven complete renal parenchyma infarction;
however, some residual tumor was evident in all but one animal. 
Conclusion: None of the Ethiodol-based modalities combined with locoregion-
al carboplatin were more efficacious for tumor ablation than EEM alone. 
dvanced imaging exams are being more frequently performed with
newer imaging techniques, and so small renal tumors are being inciden-
tally discovered more often in elderly patients and high-risk patients. This
has prompted interest in minimally invasive therapies for the management of small
tumors in selected patients. For treatment of kidney tumors, there are reasonably
minimal invasive surgical alternatives such as laparoscopic nephrectomy (1) as well as
the minimally invasive percutaneous procedures. A variety of energy-based modali-
ties, such as radiofrequency thermal ablation, microwave thermotherapy, laser intersti-
tial therapy, high intensity focused ultrasound and cryoablation have been investigated
in that regard (2). Radiofrequency ablation (RF), which is the modality with the most
reported experience, has achieved excellent results for treating small exophytic tumors
(< 3.5 cm), but successful treatment is less likely as the tumor size increases or the
location becomes more central. Complete treatment of most tumors requires one or
more overlapping ablations (3). Because the size of the thermal lesion created by RF
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Aablation is influenced by blood flow, which causes heat loss
by convection, renal artery embolization was successfully
combined by RF ablation to increase the anticancer
efficiency (4). 
Although transcatheter embolization was the first
minimally invasive alternative/adjuvant treatment
modality to surgery, its role for the treatment of renal
tumors has steadily diminished (5). Yet renal embolization
still plays a limited role treating patients who are not
surgical candidates, and it is also considered as an adjunc-
tive presurgical therapy; this has recently been shown to
provide a survival benefit (6).
Transcatheter embolization is currently used almost
exclusively for palliative treatment since it is not consid-
ered to be a curative minimally invasive treatment
modality. That is mainly because of the imperfect tissue
ablation achievable with the embolic materials used in the
past. Among the nephron-sparing approaches,
transcatheter embolization could, in theory, yield the
maximal benefit by offering precise tailoring of the
intervention based on the vascular anatomy. Although
ethanol alone produces embolization at the capillary level,
many studies have shown that some areas of tumor remain
viable even in the presence of widespread infarction (7
10). The reason for this non-optimal anti-tumor effect
appears to be the inability of the embolic material and
administration techniques to achieve complete arteriocapil-
lary infarction.
Ethiodized oils (Ethiodol or Lipiodol, which are iodized
ethyl ester of poppy seed oil fatty acids) added to ethanol
have proven to be beneficial both experimentally and
clinically (11 13). Experimentally, a 1:1 ethiodized-
oil/ethanol mixture (EEM) was shown to be an efficacious
agent for inducing capillary embolization that was capable
of producing complete ablation, provided that concurrent
occlusion of the main renal artery was also performed (14).
Furthermore, EEM has been proven to be a distinct
embolic agent that is distinguishable from ethanol, accord-
ing to its different mechanism of action (15). A previous
rabbit study has shown (16) that 1:1 EEM complemented
with pure ethanol injection and/or coil placement had the
potential to achieve complete ablation of kidneys that had
been inoculated with VX-2 carcinoma, but the treatment
was not curative in all cases. Carboplatin is an anti-cancer
drug that is available in powder form and so it is suitable to
mix with other agents. Carboplatin has been reported to
accumulate in VX-2 carcinoma if used in conjunction with
temporary flow retardation (17). 
The purpose of the study was to establish whether EEM
capillary embolization combined with selective intraarter-
ial carboplatin administration could further improve the
efficiency of EEM to achieve 100% histologically proven
tumor ablation in rabbit kidneys that had been inoculated
with VX-2 carcinoma. Also, with using this tumor model,
we studied the efficacy of the different components of this
combined treatment modality, that is, the effects of short-
term intraarterial carboplatin infusion and the effects of
ethiodized-oil-enhanced carboplatin chemotherapy with or
without arterial occlusion. 
MATERIAL AND METHODS
All the experimentation involving animals was approved
by the Institutional Animal Care and Use Committee at
our hospital. The animals were maintained in facilities
approved by the Association for Assessment and
Accreditation of Laboratory Animal Care (AAALAC
International) and in accordance with current U.S.
Department of Agriculture, Department of Health and
Human Services and National Institute of Health regula-
tions and standards.
A total of 34 New Zealand white rabbits (mean weight:
2.57 0.44 kg each, range: 1.5 3.5 kg) was treated and
evaluated. Each rabbit was sedated with an intramuscu-
larly injection of 0.5 microgram Buprenex (buprenorphine
hydrochloride, Reckitt Benckiser Healthcare [UK] Ltd),
and anesthesia was induced and maintained with isoflurane
(2 5%) and oxygen (1 L/min). Antibiotics (enrofloxacin,
Baytril, 5-mg/kg i.m.; Bayer Corporation, Agriculture
Division, Animal Health, Shawnee Mission, KS) were
given pre-procedurally and then repeated daily for up to
five days. The antero-posterior and lateral baseline chest
radiographs were obtained. 
Tumor Inoculation 
The right femoral artery was surgically exposed and a 3-
Fr catheter (Cook Inc., Bloomington, IN) was inserted; 100
units/kg of heparin was then administered. Under fluoro-
scopic monitoring, the catheter was advanced into the right
renal artery. Contrast (Conray 60%, iothalamate
meglumine, Mallinckrodt Inc., St. Louis, MO) was hand-
injected and digital subtraction angiography was used to
document the vascular anatomy. 
The catheter was then advanced in the mid-portion of
the right renal artery beyond the orifice of the capsular
artery to avoid tumor seeding in the perirenal tissues.
Using a tuberculin syringe, 0.05 mL of freshly harvested
and prepared VX-2 tumor fragments (~0.5 mm) were
loaded into the catheter, and diluted contrast was used to
slowly wash them into the renal vasculature. In an effort to
avoid tumor seeding outside of the target vasculature, the
catheter was removed without additional injection of
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ligated, the wound closed and the animal was allowed to
recover from anesthesia. All the inoculations were
performed by the same interventional radiologist. 
Treatment
One week after inoculation, the animals were
anesthetized as described earlier. The left femoral artery
was surgically isolated, a 3-Fr catheter was inserted and 100
units/kg of heparin was administered. Abdominal aortogra-
phy and selective right renal arteriography were then
performed. The kidney was considered suitable for the
treatment if no vascular occlusion due to the inoculation
was observed more proximal than the interlobular artery
level. These arterial occlusions at the interlobular and
arcuate levels were considered as indirect evidence for the
presence of inoculated tumors. For treatment, the catheter
was then advanced into the mid-portion of the right renal
artery, beyond the origin of the capsular artery. To avoid
inducing spasm in this delicate vasculature, advancement of
the catheter was performed without using a guidewire. The
positioning of the tip of the catheter into the mid-portion of
the renal artery served three goals: 1) it facilitated even
distribution of the capillary agent, 2) it helped avoid filling
the capsular artery with the capillary agent and/or loosing
the carboplatin that had been infused outside the target
vasculature, and 3) it utilized the patent capsular artery as a
buffering mechanism during injection of the non-
radiopaque ethanol to avoid inadvertent embolization.
The inoculated parenchymal VX-2 tumors were divided
into 7 groups that were subjected to one of the different
locoregional treatments (Table 1, see Methods and
Agents).
Group 1, “sham” treatment (control): 
10 mL of saline was infused into the main renal artery at
a rate of 1 mL/min.
Group 2, intraarterial chemotherapy: 
Five mg (Group 2A; n = 2) and 10 mg (Group 2B; n = 4)
of carboplatin powder (C) (Paraplatin; Bristol Myers
Squibb, Princeton, NJ) mixed with 10 mL of saline was
infused at a rate of 1 mL/min. 
Group 3, Ethiodol-enhanced chemotherapy: 
Carboplatin powder (50 mg) was suspended in 2.5 mL of
Ethiodol (Savage Laboratories, Malville, NY) and then it
was injected into the main renal artery. No ethanol was
injected behind the carboplatin/Ethiodol (CE).
Group 4, Ethiodol-enhanced chemotherapy + arterial
occlusion: 
Carboplatin powder (50 mg) was suspended in 5 mL of
Ethiodol, and a uniform amount (0.30 mL) was injected
into the main renal artery. Pure absolute ethanol was then
injected in increments (0.1 0.2 mL) until arterial stasis
was achieved (CE + ethanol).
Group 5, drug-enhanced capillary embolization +
arterial occlusion: 
Equal amounts of absolute ethanol (1.5 mL) and Ethiodol
(1.5 mL) were drawn into a 3 cc syringe and mixed
together by slowly moving an air bubble in the syringe.
The 1:1 mixture (EEM) became crystal clear within a
minute. A total of 3 mL of the EEM was then injected into
the vial containing 50 mg of carboplatin and this was
mixed to form a homogeneous emulsion (16.7 mg of
Konya et al.
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Table 1. Cumulative Data
Group No. Method Agents* Administration Follow-up Days % Tumor
1 5 “Sham” Treatment (control) Saline 10 mL 17.0  3.0 75.5  14.6
1 mL/min
2A 2 IA chemotherapy C 5 mg/10 mL 18.0  4.2 41.5  24.8
1 mL/min
2B 4 IA chemotherapy C 10 mg/10 mL 21.0  0.0 43.3  09.3
1 mL/min
3 4 Ethiodol-enhanced chemotherapy CE 20 mg of C/mL 19.8  2.5 51.5  14.5
4 4 Ethiodol-enhanced chemotherapy CE + Ethanol 10 mg of C/mL 20.3  1.5 25.7  06.5
+ Arterial occlusion
5 5 Drug-enhanced capillary embolization C-EEM +  16.7 mg C/mL 21.0  0.0 14.2  10.6
+ Arterial occlusion Ethanol
6 5 IA chemotherapy + Capillary embolization C + C-EEM +  10 mg of C/10 mL 17.2  8.5 15.2  13.3
+ Arterial occlusion Ethanol EEM
7 5 Capillary embolization EEM + Ethanol EEM 21.0  0.0 23.0  16.0
+ Arterial occlusion
Note. IA = intra-arterial, C = Carboplatin, CE = Carboplatin + Ethiodol, C-EEM = Carboplatin + 1:1 EEM, EEM = 1:1Ethiodol-ethanol mixture, Bold line 
separates the groups that differ significantly on the base of amount of tumor growths (% tumor) observed at 3 weeks.carboplatin/mL). The Carboplatin-EEM (C-EEM) was
injected slowly and intermittently into the main renal
artery until capillary stasis was achieved. Pure absolute
ethanol was then injected behind the C-EEM until
complete arterial stasis occurred (C-EEM + ethanol).
Group 6, intraarterial chemotherapy + capillary
embolization + arterial occlusion: 
Ten mg of carboplatin dissolved in 10 mL of saline was
infused into the main renal artery at a rate of 1 mL/min.
EEM (1:1) was then injected slowly and intermittently until
capillary stasis occurred. Pure absolute ethanol was
injected in 0.1-mL increments behind the EEM until
complete arterial stasis was achieved (C + ethanol).
Group 7, capillary embolization + arterial occlusion: 
A 1:1 EEM was prepared as described in Group 5. The
EEM was injected into the main renal artery slowly and
intermittently until capillary stasis occurred. Pure absolute
ethanol was then injected in 0.1 0.2 mL increments until
arterial stasis was accomplished (EEM + ethanol).
In summary, carboplatin powder as a chemotherapeutic
agent was mixed with Ethiodol or 1:1 EEM and it was also
prepared with saline for intraarterial infusion. Ethiodol was
used alone as a drug vehicle and also as part of the 1:1
EEM. EEM was used as a capillary embolic agent and also
as a carrying agent (drug vehicle). Absolute ethanol as an
embolic agent was used exclusively for arterial occlusion
following capillary embolization with one of the ethiodized
oil based agents.
The agents with Ethiodol were injected into the main
renal artery slowly and intermittently until capillary stasis
was achieved. Using a tuberculin syringe, the amount of
the embolic agent was measured in hundredths of a
milliliter. The 0.2 mL of dead-space of the catheter was
taken into account during this measurement. Capillary
stasis was determined by observing significant slowing of
arterial flow and/or by observing the radiopaque oily
embolic agent in the renal vein. When it was used, pure
absolute ethanol was then injected in increments (0.1 0.2
mL) until arterial stasis was achieved. 
After the treatment procedure was completed, the
catheter was withdrawn in the abdominal aorta, reposi-
tioned above the orifice of the treated renal artery, and
then the subtraction aortograms were obtained to establish
the post-treatment status (Groups 1, 2) or to document the
occlusion of the renal artery (Groups 3 7). The catheter
was then removed, the left femoral artery ligated, the
incision closed and the animal was allowed to recover from
anesthesia. Antibiotics were given daily for five days. All
the treatments were performed by the same experienced
interventionalist.
Follow-up
Three weeks following treatment, the animal was
anesthetized as before. The antero-posterior and lateral
chest films, including those of the abdomen, were
obtained. Using either of the femoral approaches, a 3-Fr
catheter was inserted into a femoral artery via surgical
cutdown, and 100 units/kg of heparin was administered.
Abdominal aortograms were obtained to document
occlusion or patency of the treated right renal artery. If the
artery was patent, then selective renal arteriograms were
also obtained. The angiograms were evaluated for arterial
patency, parenchymal staining and the presence of tumor. 
The animals were sacrificed with using Beuthanasia-D (1
mL; Schering-Plough Animal Health Corp., Kenilworth,
NJ), and complete necropsy was then performed. The two
largest perpendicular diameters of the kidneys, which were
macroscopically much larger than normal, were measured
at an accuracy of 5 mm. The measurements involved the
perirenal tissues (largely adipose tissues). Because of the
presence of significant amounts of perirenal adipose tissue,
in the case where the kidney showed a definite reduction
in size macroscopically, we did not measure the kidney’s
diameters. The treated kidneys were fixed in 10%
buffered formalin. Those kidneys showing a reduction in
size were cut transversally into a series of 2 3-mm thick
histological blocks, whereas only a limited number of
sections (2 4) were obtained from those kidneys that
showed significant enlargement due to uncontrolled tumor
growth. Histologic slides were prepared from each section
and these were stained with hematoxylin and eosin (H &
E) for light microscopic examination. All the histological
slides were evaluated by the same board certified veteri-
nary pathologist for the remaining viable kidney
parenchyma and tumor. For a semiquantitative analysis, all
the slides were scanned (HP scanjet 7400c) into a jpg file
with using an overlay grid. For each animal, the total
number of squares stained blue/purple per section was
counted, as was the total number of squares. The slides
were then microscopically assessed to confirm whether the
blue/purple squares contained tumor, inflammation or
mineral. The number of squares containing tumor was
divided by the total number of squares to give a percent of
tumor-squares. The amount of remaining viable tumor in
each kidney was then established on the basis of the % of
the squares that contained viable tumor (Fig. 1). 
Statistical Analysis 
The histological data concerning the amount of remain-
ing viable tumor in each kidney (% of the grid squares that
contained viable tumor) was statistically analyzed. For
statistic analysis, the Mann Whitney U-test was performed
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Inc., Chicago, IL). A p value of less than 0.05 was consid-
ered to indicate a statistically significant difference. 
RESULTS
As for the tumor growth in the kidney parenchyma, the
tumor model based on intraarterial inoculation worked
quite dependably. In some cases, the inoculated tumor
fragments caused occlusion of vessels at the
segmental/subsegmental levels, which rendered these
kidneys unsuitable for treatment (the relevant reported
numbers do not reflect these kidneys). The peripheral
arterial occlusions related to tumor fragments (at the
interlobular and arcuate levels) were more frequently
observed angiographically. These kidneys were considered
as adequate for intraarterial treatment. Leg paralysis
related to spinal injury (unrelated to treatment) and
surgical cut-down, respectively, resulted in a shorter than
expected follow-up period for four animals. The majority
(25 of 29) of the treated animals (not including the “sham”
treated group) were kept alive until the scheduled sacrifice
at 3-weeks after the procedures (Group 2A+B [5/6], Group
3 [3/4], Group 4 [3/4], Group 5 [5/5], Group 6 [4/5],
Group 7 [5/5]). 
The antero-posterior and lateral chest radiographs were
evaluated for pulmonary embolization. None of the
radiographs showed any lesions related to venous
embolization, even in cases where confluent renal venous
filling of Ethiodol-containing embolic agent was observed
during and/or after the embolization. In spite of using non-
radiopaque pure ethanol for arterial occlusion and without
employing a protective balloon catheter, no complications
were experienced that could have been caused by inadver-
tent ethanol injection.
Angiographically, permanent renal artery occlusion was
verified in 14 of 19 kidneys (Groups 4 7); angiography
was not performed in five kidneys (1 in Group 4 and 4 in
Group 6) for technical reasons [such as equipment failure
and scheduling conflicts for the animals that were sacrificed
earlier than the planned 3-weeks follow-up]. However, all
these 19 kidneys (n = 4 in Group 4, n = 5 each in Groups
5 7), were uniformly reduced in size, which indicated
renal artery occlusion. These 19 kidneys were cut transver-
sally in their entirety, resulting in a total of 286 slides
(mean: 15 2, range: 12 19 slices per kidney) that were
examined microscopically. All the other treated kidneys
(Groups 2A, 2B, 3) showed completely patent renal
arteries angiographically, and no response to the treatment
was seen macroscopically. Morphologically, these kidneys
were identical to those that received saline infusion
(“sham” treatment in the control kidneys Group 1), and
there was no difference in the average sizes of the renal
specimens. Only a few histological blocks (2 4) that did
not cover the total cross sections were randomly selected
from these kidneys; these random sections were examined
histologically.
Group 1:”Sham” treatment (control) (n = 5)
We started the study with the control group (“sham
treatment”) to verify the appropriateness of the tumor
model. The tumor growth was so aggressive that only one
of five rabbits could be kept alive for four weeks after the
inoculation (3 weeks after the saline infusion treatment).
Two rabbits were sacrificed at 14 days and another two at
18 days after the saline infusion, respectively. Angiograms
(Fig. 2) and necropsy verified completely patent renal
arteries and enlarged kidneys that were occupied by
multifocal tumors (average size: 6.6 4.3 cm).
Histologically, the renal parenchyma was replaced by
coalescing nodules of VX-2 carcinoma. Some viable renal
parenchyma was present and this contained hemorrhage
and congestion. 
Group 2: Intraarterial chemotherapy (n = 6)
Konya et al.
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Fig. 1. The amount of residual tumor remaining in the kidney at
post treatment was assessed from H & E stained sections of
paraffin-embedded, formalin-fixed tissues (see text). The figure
contains all the slides (2/kidney) analyzed for the non-responder
kidneys from Group 1 (“sham” treatment).Because we had no previous experience with the dose of
carboplatin for renal artery infusion, we initially treated
two rabbits with 5 mg of the drug (Group 2A). These two
rabbits were followed for 21 and 15 days, respectively.
Subsequently, four rabbits were treated with 10 mg of
carboplatin (Group 2B) and they were followed for three
weeks after treatment. Either dose of the carboplatin had
no visible effect on the local growth of the tumor. The
average size of the treated kidneys was 7.4 6.1 cm and
they were completely occupied by multifocal tumor.
Histologically, the renal parenchyma was replaced with
coalescing VX2 carcinoma nodules. 
Group 3: Ethiodol-enhanced chemotherapy (n = 4)
A mean of 0.46 0.03 mL CE (20 mg carboplatin/mL
Ethiodol) was injected over 10 2.8 minutes in four
kidneys. Post-procedure aortography verified stasis (there
was no parenchymal staining on the subtraction films) with
patency of the renal arteries. The average dose of adminis-
tered carboplatin was 9.15 0.61 mg/kidney. Three renal
arteries showed complete patency at the time of the 3-
week follow-up; the forth animal was sacrificed at 16 days
post-procedure and angiography was not performed due to
technical reasons. In all four animals, both macroscopic
and microscopic evaluation verified that the tumors were
not affected by the treatment. The average size of the
kidneys was 6.6 4.5 cm. Histologically, the renal
parenchyma was largely replaced by coalescing VX-2
carcinoma. 
Group 4: Ethiodol-enhanced chemotherapy + arterial
occlusion with ethanol (n = 4)
To decrease the viscosity of the CE emulsion used in
Group 3, the amount of carboplatin suspended in the
Ethiodol was reduced from 20 mg/mL to 10 mg/mL. A
uniform amount of CE (0.3 mL) was injected continuously
to achieve capillary stasis. Pure ethanol (0.34 0.15 mL)
was injected behind the CE until complete arterial stasis
was accomplished. Three animals were sacrificed at three
weeks, and one animal was sacrificed at 18 days post-
procedure. For technical reasons, no angiography was
performed in the latter. Angiographically, all the other
three arteries were completely occluded. Grossly, all four
kidneys exhibited renal artery occlusion with complete
infarction. However, on microscopic examination, variable
sized VX-2 tumor nodules were present in the kidneys that
were completely infarcted. 
Group 5: Drug-enhanced capillary embolization +
arterial occlusion with ethanol (n = 5)
Treatment was performed with C-EEM in the five
inoculated kidneys in which capillary stasis required the
injection of 0.46 0.12 mL of C-EEM during 14.6 7.4
minutes. In three of five kidneys, injection of C-EEM
caused arterial stasis and there was no room in the main
renal artery to inject ethanol. The calculated mean dose of
carboplatin was 7.7 1.9 mg/kidney (range: 5.8 10.5 mg).
At three weeks post-procedure, all the renal arteries
remained completely occluded; macroscopically, all the
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Fig. 2. “Sham treatment” (03L-306). 
A. Selective right renal arteriogram (for technical reasons, the access was created from the right carotid artery): Normal right kidney
(electronic magnification 1X). 
B. Selective right renal arteriography: 25-day post inoculation (18-day post saline infusion): The right kidney is enormously increased in
size and is completely occupied by multifocal tumors (same electronic magnification). 
ABkidneys were significantly reduced in size (Fig. 3).
Histologically, the renal parenchyma in all the kidneys was
completely infarcted. The capsular surface and the renal
hilus contained granulation tissue and inflammation, which
was indicative of tissue repair/resorption. Some tumor
growth was evident in all the animals, but the amount of
tumor growth was significantly less than that seen in
Groups 1 3. 
Group 6: Intraarterial chemotherapy + capillary
embolization + arterial occlusion with ethanol (n = 5)
Five inoculated kidneys were treated with a short-term
infusion of 10 mg of carboplatin, and this was followed by
capillary embolization with 1:1 EEM. Achieving capillary
stasis required 0.45 0.09 mL of EEM that was injected
during 9.2 2.4 minutes. Pure ethanol (0.25 0.2 mL) was
injected behind the EEM, resulting in complete arterial
stasis in four kidneys. One animal had to be sacrificed at
two days post-procedure because of leg paralysis related to
the surgical cut-down. The other four animals were
followed for three weeks. For technical reasons, no angiog-
raphy was performed in three of these animals. Necropsy
revealed that all the kidneys harvested at three weeks
were reduced in size, which indicated macroscopically
successful embolization.
Histology revealed complete parenchyma infarction in
all the kidneys, with some residual tumor growth in all but
one kidney. The one kidney that was harvested two days
after the treatment was completely tumor-free. 
Group 7: Capillary embolization + arterial occlusion
with ethanol (n = 5)
A mean of 0.38 0.07 mL of 1:1 EEM that was injected
during 32.8 5.5 minutes led to capillary stasis. Complete
arterial stasis was achieved in all kidneys ; in four kidneys,
this required injection of pure ethanol (0.15 mL for each of
Konya et al.
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Fig. 3. Carboplatin-EEM Embolization (04L-408). 
A. Right renal arteriogram: Normal vasculature (electronic magnifi-
cation 2X). 
B. Plain film obtained immediately after embolization. 0.42 mL of
embolic agent completely filled the arteriocapillary system: The
parenchyma stains densely and homogeneously, while the
segmental-interlobar-interlobular arteries are almost contiguously
filled. The EEM embolization resulted in complete arterial stasis; no
ethanol was injected into the renal artery. Note that the capsular
artery is also occluded. 
C. Plain abdominal film obtained 3-week post treatment. The right
kidney is reduced in size, and its parenchymal density is almost
homogeneously increased. The left kidney shows compensatory
hypertrophy.
AB
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4 kidneys). Angiographically, all the renal arteries
remained completely occluded at 3-weeks (Fig. 4).
Necropsy revealed that all the kidneys were significantly
reduced in size. Histologically, complete parenchymal
infarction was found with some tumor growth in all
kidneys.
Statistical Analysis
The histological data concerning the amount of remain-
ing viable tumor in each treated kidney (% of the grid
squares containing viable tumor) was statistically analyzed
and compared (Table 1). Comparing Groups 2 and 3 to
Group 1 (control), the amount of viable remaining tumor
was significantly less in Group 2, but not in Group 3.
Compared to the control group (75.5 14.5), significantly
less viable tumor was found in the treated kidneys of the
animals in Groups 4-7 (25.7 6.5, 14.2 10.6, 15.2 13.3,
23.0 16.0; p = 0.021, 0.014, 0.014, 0.014, respectively),
indicating there was efficient treatment by the different
ethiodized oil based modalities and combined with success-
ful arterial occlusion (Fig. 5). However, there was no statis-
tical difference among groups 4, 5, 6 and 7, and this
implied that none of the treatments increased the efficacy
of the 1:1 EEM embolization (Groups 4 6 vs. Group 7).
The tumors found in the completely infarcted renal
parenchyma may have resulted from residual tumors, local
recurrences from perirenal components of the original
lesions or from metastases that occurred during the 3-week
AB
Fig. 4. EEM embolization (03L-326). 
A. Normal selective right renal arteriogram (magnification 1X). 
B. Selective right renal angiogram 1-week post VX-2 tumor inoculation:
Several peripheral branches are occluded at the interlobar-interlobular-
arcuate level throughout the kidney, the intensity of the parenchymal staining
is slightly uneven (magnification 1X). 
C. Selective right renal arteriogram obtained 3-weeks post EEM emboliza-
tion: The right renal artery is occluded, except for a 1-cm long stump that
carries the patent capsular artery. The capsular artery increased in caliber,
(its branches supply the perirenal soft tissue), but there is no parenchymal
staining. Note that the right kidney is slightly reduced in size with moderately
increased radiopacity, indicating residual Ethiodol and mineralization (normal
view).
Cfollow-up (Fig. 6). 
DISCUSSION
Previous studies have shown that addition of ethiodized
oil to ethanol is beneficial and it helps facilitate homoge-
neous distribution (12) and retention of alcohol in the
capillaries (11). Based on these observations, other studies
have been conducted to further investigate the possibilities
of using 1:1 EEM renal embolization (14 16). It was
initially determined that EEM injections alone did not
produce permanent capillary embolization in normal
porcine kidneys. Only prompt and permanent occlusion of
the main renal artery could preserve the capillary
embolization achieved with using EEM. Based on these
findings, a two-phase embolization technique consisting of
homogeneous capillary embolization with 1:1 EEM and
ethanol/mechanical occlusion of the main arterial compart-
ment facilitated by temporary balloon occlusion, was
developed for achieving histologically complete renal
ablation in normal swine (14). In a rabbit study, the
temporal histopathological changes after renal emboliza-
tion with 1:1 EEM were evaluated to elucidate the
mechanism of action (15). The results showed that 1:1
EEM did not produce immediate spasm, arterial wall
damage or early parenchymal changes, which allowed the
EEM to penetrate all the way through the capillaries (15).
These parenchymal events are distinctively different from
those produced by ethanol alone when following intraarte-
rial injection, that is, the early fibrinoid necrosis of the
glomerular tufts and the glomerular changes are consistent
with direct cellular toxicity rather than thrombosis-induced
hypoxia (18). EEM capillary embolization combined with
main renal artery occlusion via ethanol injection prevents
the EEM from passing through the capillaries to the venous
side. Based on the different mechanism of actions, 1:1 EEM
is considered to be a distinct embolic agent that differs
from pure absolute ethanol (15).
In a rabbit study, 1:1 EEM was administered in combina-
tion with pure ethanol and coil placement for achieving
histologically complete transcatheter ablation of kidneys
that were implanted with VX-2 carcinoma (16). Three
weeks after the procedure, the treated kidneys were
sectioned and evaluated histologically for viable tumor.
Altogether, five of 12 kidneys (41.6%) and 139 of 151
slides (92.1%) proved to be tumor free. However, some
microscopic viable tumors were found, indicating that
renal embolization with using 1:1 EEM as a capillary agent
in combination with other embolic agents (ethanol, coil)
effectively controlled the VX-2 tumor that was confined to
the kidney parenchyma in some of the rabbits, but it was
not curative in the majority of cases. It was speculated that
one possible reason for the presence of residual tumors
was the failure to fill the entire renal vasculature with
EEM. 
Carboplatin, an anticancer agent, was selected for our
study because it is available in powder form, which allows
it to mix with Ethiodol. In an acute study, the correct
carboplatin concentration, following systemic, intraarterial
and locoregional administration of absorbable gelatin
powder (Gelfoam) and starch microspheres (Spherex), was
assessed for treating VX-2 tumors that were implanted into
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Fig. 5. A comparison of tumor retention and renal embolization
between the control and treated groups. Kidney sections from two
animals from each group are scanned using the HP scanjet
7400c (magnified x 2). Group 1 is the control and it has the most
tumor, as demonstrated by the blue/purple areas (see also Fig. 1)
and this was confirmed histologically as being VX2 carcinoma.
The tumor is diffusely spread throughout the kidney. Groups 2A,
2B and Group 3 have less VX2 carcinoma than the control group,
and the tumor is still distributed throughout the renal parenchyma.
Groups 4, 5, 6 and 7 are all similar to each other and they are
very different from Groups 1, 2A, 2B and 3. However, Group 4
appears to have more blue/purple tumor than Groups 5, 6 and 7.
The kidneys of these latter 4 groups are smaller and completely
embolized. The remaining tumor is not diffusely distributed
throughout the parenchyma, but it is generally at the capsular
surface, in the attached peri-renal fat or in the pelvis of the
kidney. The blue/purple is either tumor or inflammation or
mineralization, and it frequently shows all three in the sections
(see Fig. 6). Ethiodol-Ethanol Capillary Embolization Combined with Carboplatin in Transcatheter Renal Arterial Embolization
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Fig. 6. Embolized kidneys from Groups 6 and 7 demonstrating the pattern of tumor re-growth. 
A. The entire kidney is sectioned, demonstrating a smaller kidney that is completely embolized. No tumor was present in any section
(score = 0) on microscopic examination. A2 (magnified x 25) and A3 (magnified x 400) demonstrate that at the capsular surface, the
outermost blue/purple is mineralization (arrow), and the inner blue/purple (arrowhead) at the junction with the necrotic parenchyma is
inflammation. 
B. The entire kidney is sectioned and this includes some adherent peri-renal fat containing blue/purple nodules (*) that are VX2 tumors.
In B2 (magnified x 25), the tumor (*) is in the peri-renal fat, and the fat is separated from the renal parenchyma by blood vessels (bv) in
the granulating renal capsule. The blue/purple (arrow) below the capsule is mineral on microscopy. B3 (magnified x 25) is a tumor (*) in
the medulla of the same section that appears to arrive from a tumor’s embolized vessel (bv). B4 (magnified x 100) demonstrated that the
tumor (*) invades from the capsular surface into the pink embolized renal parenchyma.rabbit liver (17). However, we thought the use of 50 mg of
carboplatin per animal was too high for a chronic study.
Our bench-top experiments showed that no more than
10 20 mg of carboplatin powder could be added to one
mL of Ethiodol or EEM for locoregional application, and
that locoregional administration of the carboplatin with
using the given drug vehicles (Ethiodol, EEM) would
technically allow for delivery of not more than 10 mg of
carboplatin per kidney. The dose for intraarterial infusion
was determined accordingly. In that way, the efficacy of
the different treatments remained comparable as far as the
carboplatin dose-range was concerned. 
As for the efficacy of the carboplatin, when used in
different forms for treating inoculated VX-2 tumors, the
study has shown that adding carboplatin to the two-stage
ethiodized oil-based capillary embolization did not
improve the overall effectiveness. When the carboplatin
was used alone, its short-term intraarterial infusion (either
the 5 mg or the 10 mg) was not effective to achieve local
tumor control and its efficacy did not differ from that of
the saline infusion. When administered as
carboplatin/Ethiodol (CE) without arterial occlusion, this
mixture produced capillary stasis in all cases at the end of
injection, but the effect proved only temporary. The renal
arteries were found to be completely patent at 3-weeks
post procedure and the tumors were not affected by the
treatment. Without prompt and permanent renal artery
occlusion, the CE washed out of the arteriocapillary bed,
allowing the tumors to continue growing out of control.
Because this phenomenon was observed in our previous
studies (14), the findings from this group prompted us to
repeat the CE treatment with arterial occlusion in four
kidneys (Group 4). At the 3-week follow-up, all 4 kidneys
showed homogeneously increased density (mineralization
plus retained ethiodized oil) on plain films, along with a
significant reduction in size. Histologically, no viable
kidney parenchyma was present, but the examined
kidneys showed an average of 29% residual tumor.
Nevertheless, permanent arterial occlusion resulted in
macroscopically successful embolization with only a 3 mg
dose of carboplatin per kidney. The fact that these kidneys
did not differ from the kidneys in Groups 5 7 may
indicate the negligible role of carboplatin in the result of
the Group 4 kidneys.
Furthermore, there was no difference among the other
responder groups either (Group 5 7). In comparison to
Group 7 (capillary embolization + arterial occlusion),
neither the capillary embolization performed with
carboplatin-EEM supplemented with arterial occlusion
(Group 5) nor the short-term intraarterial carboplatin
injection, which was used prior to EEM embolization, and
followed by arterial occlusion (Group 6) resulted in a
better overall outcome. Again, the addition of carboplatin
to the treatment regimen in two different forms did not
improve the results obtained from the original two-stage
capillary embolization.
Histological analysis (286 histological slides/19 kidneys)
demonstrated macroscopically successful embolization
with histologically proven complete renal parenchymal
infarction in Groups 4 7. In contrast, viable tumor growth
was evident in all the animals except one from Group 6,
which was euthanized two days after treatment. However,
this tumor growth was significantly less than that observed
in the control animals (Group 1). The kidneys that
responded to treatment in Groups 4 7 were macroscopi-
cally identical. The histology did not reveal any statistically
significant difference among these kidneys, based on the
residual viable tumor. These observations indicate that the
addition of carboplatin in any form did not increase the
therapeutic efficacy of 1:1 EEM embolization, nor did it
render the kidneys tumor-free. Simultaneously, these
observations also suggest that the complete renal
parenchymal infarction seen in Groups 4 7 was achieved
by using some form of ethiodized-oil based capillary
embolization, followed by prompt and permanent renal
artery occlusion with ethanol. In that regard, all these
favorable results may be uniformly attributed to
ethiodized oil capillary embolization complemented by
renal artery occlusion, and this is irrespective of the use of
carboplatin at all; the key factor here is the use of the
ethiodized oil as an efficacious capillary agent. Since the
completion of the reported study, this assumption has
already been confirmed by a pilot study in which pure
ethiodized oil was used alone as a single capillary agent,
and this was followed by arterial occlusion (19).
One of the main limitations of the study is that it used
only a single time-point for evaluation. Consequently, the
origin of the viable tumors observed 3-weeks after
treatment could not be determined. The presence of viable
tumors in the shrunken kidneys 3-weeks after treatment
may be attributed to real “residual tumors” that have
survived the ablation. Nevertheless, the tumors grew much
more rapidly in the non-responder kidneys and by the end
of 3-weeks they had formed large coalescent tumor noduli
in the considerably enlarged kidneys. The observed tumors
may also be attributed to activation of dormant tumor cells
by growth factors and angiogenesis, but it is also possible
that extrarenal tumor cells invaded the granulation tissue
and partially replaced the completely infarcted renal
parenchyma. These observations underline the necessity of
using multiple time-points for adequately evaluating the
efficacy of the various treatments. 
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The treatment protocol was a bit uneven, and this was
caused by some technical problems. In some cases, angiog-
raphy was not performed at the time of tissue harvest
(Groups 4 and 6). Yet the signs on the plain radiographs
and the macro- and microscopic evaluations were identical
to those observed after angiographically proven renal
artery occlusions. In Group 5, ethanol was not injected into
the renal artery in 3 of 5 kidneys because the C-EEM had
already occluded the arterial compartment. Follow-up
angiography verified complete arterial occlusion of these
renal arteries, so the lack of ethanol injection was not
considered as a diversion from our protocol, which aimed
at establishing prompt and permanent arterial occlusion so
as to preserve the effect of capillary embolization.
As for possible clinical use, a method of transcatheter
embolization that could achieve total tissue/tumor ablation
would be a curative alternative to minimally invasive
surgical procedures, as well as to percutaneous energy-
based minimally invasive treatments. The operative times,
blood loss, procedure-related morbidity, the degree of
invasiveness, patient discomfort and pain, and the length
of the hospital stay are all factors that favor catheter-based
interventions. Also, the capillary embolization technique
could be utilized for tumors without size limitation (20).
More research is needed to develop an “ideal” embolic
agent that’s capable of ablating tissues with the efficiency
of surgical removal. As a first step, the part of this study
that poduced macroscopically successful results with
histologically verified residual tumors, in spite of complete
parenchymal infarction, should be repeated with an
adequately shortened follow-up time points. Further
studies are warranted to elucidate the mechanism of action
of ethiodized oil-based capillary embolization that’s
combined with prompt and permanent arterial occlusion. 
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